World markets are mixed and Korean shares slump on AI jitters
BANGKOK (AP) — World shares and U.S. futures were mixed on Tuesday following a rebound for AI stocks…
Wall Street Pessimism Has Made Universal Health Services (UHS) Stock A Top Extreme Value Stock To Buy Now
Universal Health Services, Inc. (NYSE:UHS) is one of the Top 10 Extreme Value Stocks To Buy Now. On…
How Advanced Micro Devices, Inc.’s (AMD) Server CPU Demand Is Broadening Its AI Growth Story
Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the stocks with rising earnings estimates and fresh catalysts. How…
Is Amazon.com, Inc. (AMZN) One of the Best AI and Technology Stocks to Buy Now?
Amazon.com, Inc. (NASDAQ:AMZN) is one of the Best AI and Technology Stocks to Buy Now. On June 18, Bloomberg…
B. Riley Raises PT on Applied Materials (AMAT) Stock
Applied Materials, Inc. (NASDAQ:AMAT) is one of the Best AI and Technology Stocks to Buy Now. On June…
Here’s Why Brown Advisory Large-Cap Growth Strategy Exited ServiceNow (NOW)
Brown Advisory, an investment management company, released its “Brown Large-Cap Growth Strategy” for the first-quarter 2026 investor letter. A…
Nearly 1 million bottles of heart, kidney medications recalled nationwide over ‘foreign substance’
Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly…
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Lime to Name Uber (UBER) as Anchor Investor in U.S. Initial Public Offering, Reuters Reports
Uber Technologies, Inc. (NYSE:UBER) is one of the most promising future stocks to buy right now. Reuters reported…
OpenAI film, dropped by Amazon, is acquired by Neon
NEW YORK (AP) — “Artificial,” Luca Guadagnino’s starry film about Sam Altman and OpenAI, has been acquired by…
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Moleculin Biotech, Inc. Moleculin Biotech, Inc. INTERIM EFFICACY – N=45 INTENT TO TREAT (ITT) Both Annamycin dose arms…
Unicycive Therapeutics Receives Complete Response Letter
— Complete Response Letter relates to deficiencies previously identified at third-party manufacturing vendor — — FDA inspection of…